DeMuro C, Clark M, Doward L, Evans E, Mordin M, Gnanasakthy A. Assessment of PRO label claims granted by the FDA as compared to the EMA (2006–2010). Value Health. 2013 Dec;16(8):1150-5. doi: 10.1016/j.jval.2013.08.2293
Gnanasakthy A, Lewis S, Clark M, Mordin M, DeMuro C. Potential of patient-reported outcomes as nonprimary endpoints in clinical trials. Health Qual Life Outcomes. 2013 May 15;11:83.
Mordin M, Hogue S, Barrows S, van Amerongen D. Safe and effective versus reasonable and necessary: is the deck stacked against medical devices? Poster presented at the 2013 ISPOR 18th Annual International Meeting; April 30, 2013. [abstract] Value Health. 2013 May; 16(3):246.
Mordin M, Copley-Merriman C, Mauskopf J, Sweeney C, Bhattacharyya S, Farup C, Beach W, Higgins L, McIntyre L. Surgical innovation: do we need a more balanced framework for evidence? Poster presented at the 2013 ISPOR 18th Annual International Meeting; May 3, 2013. [abstract] Value Health. 2013 May; 16(3):A247.
McIntyre LF, Beach WR, Higgins LD, Mordin MM, Mauskopf J, Sweeney CT, Copley-Merriman C. Evidence-based medicine, appropriate-use criteria, and sports medicine: how best to develop meaningful treatment guidelines. Arthroscopy. 2013 Mar 18;29(7):1224-9.
Gnanasakthy A, DeMuro-Mercon CJ, Clark MJ, Mordin MM, Thomas S. Role of patient-reported outcome measures in the assessment of central nervous system agents. Ther Innov Regul Sci. 2013;47(5):613-8.
Hutchison R, Mordin MM, Albright Y, Zhang M, Vallow S. Hospital resources associated with intravenous patient-controlled analgesia in the management of acute pain following orthopedic or gynecologic surgery. Poster presented at the Midyear Clinical Meeting of the American Society of Health-System Pharmacists; December 2005.
Hamilton J, Mordin MM, Zhang M, Olson W, Hewitt D. Logistics of intravenous patient-controlled analgesia in the treatment of acute pain following orthopedic or gynecologic surgery. Poster presented at the Annual Meeting of the American Society of Anesthesiologists; October 2005.
Mordin MM. Practical applications of pharmacoeconomic and outcomes research in phase iv studies. Poster presented at the CBI's 6th Annual Phase IV Clinical Trials Conference: Design Research Programs to Meet Clinical, Regulatory and Marketing Objectives; September 2005. Philadelphia, PA.
Mordin MM, Gordon D, Anastassopoulos K, van Bretta A, Richardson D, Goss T. A multicenter, prospective, observational study of intravenous patient-controlled analgesia (IV-PCA) resource utilization (RU) in acute postoperative pain management. Poster presented at the Annual Meeting of the American Society of Health-System Pharmacists; June 2005.
Zhang M, Anastassopoulos K, Hutchison R, Olson W, Goss T, Hewitt D, Gargiulo K, Siccardi M, Mordin MM. Summary of hospital logistics associated with intravenous patient-controlled analgesia (IV-PCA) for acute postoperative pain management. Poster presented at the 2005 ISPOR 10th Annual International Meeting; May 2005. Washington, DC.